v3 Template
A

Antiverse

Biotechnology / Drug Discovery ~30 employees
Founded
--
Employees (Est.)
~30
3 leaders known
Total Funding
$7.6M
Funding Rounds
2
Last Funding
2024-10-15

About Antiverse

Antiverse is an AI-driven techbio company based in Cardiff, UK, with offices in Boston, MA, specializing in antibody design for challenging drug targets such as G-protein coupled receptors and ion channels. The company combines machine learning and advanced cell line engineering to develop de novo antibody therapeutics, collaborating with top global pharmaceutical companies and building a strong internal pipeline across various indications.

Products & Services

Computational Antibody Design Technology:Next-generation technology using machine learning to design antibodies for challenging targets like G-protein coupled receptors and ion channels, reducing the timeline from target identification to functional antibody to just 6 months.
Target-Specific Antibody Libraries:Designed for each target using models to predict high-binding probability sequences without pre-existing data.
Screening and Multiparameter Clustering:Deep sequencing and clustering of antibody sequences across 20 properties to identify lead candidates for functional validation.

Specialties

Antibody Design Machine Learning in Drug Discovery G-Protein Coupled Receptors (GPCRs) Ion Channels Computational Drug Discovery AI-Driven Therapeutics

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Seed
T: -
FT: Seed
A: 4600000
MR: -
FA: $4.6M
FAN: 4600000
D: 2024-10-15
FD: 2024-10-15
6 investors
2 RT: Seed
T: -
FT: Seed
A: 3000000
MR: -
FA: 3 million USD
FAN: 3000000
D: 2023-03-02
FD: 2023-03-02
8 investors
Seed Latest
2024-10-15
$4.6M
6 investors (Pro only)
Seed 2023-03-02
$3.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

B

Ben Holland

Co-Founder

M

Murat Tunaboylu

Co-founder

R

Rowina Westermeir

Founder

Recent News

Antiverse Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology / Drug Discovery
Company Size
~30 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro